Dimensions | Barriers on supply side | Barriers on demand side |
---|---|---|
Geographic accessibility | Travel restrictionsa: A3, A4, A5, A13, A20, A28 Lack of transportationb: A9, A19, A22 | Travel restrictionsa: A1, A3, A4, A8, A10, A11, A12, A13, A16, A19, A24, A28 Lack of transportationb: A9, A10, A25 |
Affordability | Increased costs for malaria control: A25, A27 Limited fiscal space/funding: A13, A25 | Economic damage from COVID-19: A4, A9, A24 |
Availability | Procurement or supply chain issue: A6, A8, A9, A10, A11, A12, A13, A14, A15, A17, A19, A22, A24, A25, A27 Delayed or suspended ongoing malaria control intervention due to COVID-19 quarantine measures: A8, A9, A11, A13, A17, A20, A22, A24, A26, A28 The shift of resource or healthcare workforce from malaria to COVID-19: A2, A5, A6, A11, A16, A20, A25 Staff absences with sick, death, quarantine, or strikes related to COVID-19: A17, A18, A20, A22, A25 Insufficient personal protective equipment for health workers: A2, A9, A22, A25 Disrupted case management: A6, A8, A15 Clinical manifestations overlap between Malaria and COVID-19: A14, A22, A29 Postponement of recruitment or training of workforce: A13 Closure of health facilitiesc: A24 Poor program promotion, awareness, and marketing strategies: A13 | Misled health advice disrupting timely management: A1, A11, A13, A25 Lack of information or knowledge on Malaria and/or COVID-19: A6, A9, A10 Closure of health facilitiesc: A12, A16 |
Acceptability | Fear of COVID-19 infectiond: A9, A12, A18, A20, A23, A25 Lack of community’s engagement in malaria campaign: A13, A23 Lack of political will/support in malaria control: A13 Fear of violence targeting health workers (assumable due to COVID-19 stigmatization): A22 Difficulties in adhering to COVID-19 hygiene measures: A23 | Fear of COVID-19 infectiond: A1, A5, A7, A8, A9, A10, A11, A15, A16, A18, A21, A23, A25, A28 COVID-19 stigma: A10 |